Financial statements Biolife
Balance sheet data of BIOLIFE
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 1 019 482,35 | 1 734 091,97 | 2 647 312,73 | 3 082 103,64 | 3 255 816,48 | 3 213 099,51 |
| A. Fixed assets | 30 820,20 | 46 205,14 | 51 254,51 | 719 943,53 | 632 421,49 | 548 447,89 |
| B. Current assets | 988 662,15 | 1 687 886,83 | 2 569 058,22 | 2 362 159,51 | 2 623 394,99 | 2 664 651,62 |
| C. Share capital contributions (basic funds) | - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 1 019 204,12 | 1 734 091,97 | 2 647 312,73 | 3 082 103,64 | 3 255 816,48 | 3 255 816,48 |
| A. Equity | -9 838,22 | 94 849,41 | 165 858,24 | 211 951,35 | 200 829,15 | 200 829,15 |
| B. Liabilities and provisions for liabilities | 1 029 042,34 | 1 639 242,56 | 2 481 454,49 | 2 870 151,69 | 3 054 987,33 | 3 054 987,33 |
| I. Long-term liabilities | - | 0,00 | 0,00 | 0,00 | 360 038,66 | 360 038,66 |
| II. Short-term liabilities | 1 029 042,34 | 1 639 242,56 | 2 484 454,49 | 2 870 151,69 | 2 694 948,67 | 2 694 948,67 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.